Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Gastrointestinal Neoplasms, Gastrointestinal Stromal Tumors”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT04530981
What this trial is testing

A Drug-Drug Interaction Study to Evaluate the Effect of Ripretinib on the Pharmacokinetics of a CYP2C8 Probe Substrate in Patients with Advanced GIST

Who this might be right for
GIST - Gastrointestinal Stromal Tumor
Deciphera Pharmaceuticals, LLC 13
Not applicableStudy completedNCT00433602
What this trial is testing

Incidence of Blood Clots in Patients Undergoing Chemotherapy for Solid Tumors

Who this might be right for
Breast CancerColorectal CancerGastric Cancer+5 more
European Organisation for Research and Treatment of Cancer - EORTC 64
Not applicableUnknownNCT05197933
What this trial is testing

Safety of Laparoscopic Resection for Gastrointestinal Stromal Tumor on Unfavorable Anatomic Site of Stomach

Who this might be right for
Gastrointestinal Stromal Tumors
RenJi Hospital 182
Testing effectiveness (Phase 2)Study completedNCT00457743
What this trial is testing

A Phase I/II Study of Sunitinib Malate (SU011248) In Patients With Gastrointestinal Stromal Tumor (GIST)

Who this might be right for
Gastrointestinal Stromal Tumors
Pfizer 36
Large-scale testing (Phase 3)Ended earlyNCT00812240
What this trial is testing

Masitinib in First Line Treatment of Gastro-Intestinal Stromal Tumor (GIST)

Who this might be right for
Gastrointestinal Stromal Tumors
AB Science 335
Testing effectiveness (Phase 2)Looking for participantsNCT05503797
What this trial is testing

Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations

Who this might be right for
Cancer Harboring BRAF AlterationsHGGLGG+1 more
Fore Biotherapeutics 254
Not applicableStudy completedNCT01084460
What this trial is testing

Follow-up of the Natural Course of the Small EUS-suspected Gastric Gastointestinal Stromal Tumors

Who this might be right for
Tumor
National Taiwan University Hospital
Testing effectiveness (Phase 2)Study completedNCT02401815
What this trial is testing

CGT9486 (Formerly Known as PLX9486) as a Single Agent and in Combination With PLX3397 (Pexidartinib) or Sunitinib in Participants With Advanced Solid Tumors

Who this might be right for
Gastrointestinal Stromal Tumors
Cogent Biosciences, Inc. 51
Not applicableStudy completedNCT01933958
What this trial is testing

Regorafenib Post-marketing Surveillance in Japan

Who this might be right for
Gastrointestinal Stromal Tumors
Bayer 72
Not applicableUnknownNCT01768104
What this trial is testing

ESTD vs. VATS for Upper Gastrointestinal Submucosal Tumors

Who this might be right for
Upper Gastrointestinal Submucosal Tumors (SMTs)Gastrointestinal Stromal Tumors (GISTs)Leiomyoma
Nanfang Hospital, Southern Medical University 200
Early research (Phase 1)Looking for participantsNCT06805825
What this trial is testing

The c-Kit Specific Antibody-Drug Conjugate NN3201 for Advanced and/or Metastatic Solid Tumors Known to Express c-Kit

Who this might be right for
Gastrointestinal Stromal TumorsSmall-cell Lung CancerAdenoid Cystic Carcinoma+4 more
Novelty Nobility, Inc. 67
Testing effectiveness (Phase 2)Study completedNCT00400569
What this trial is testing

Phase II Study of Sunitinib Malate for Metastatic and/or Surgically Unresectable Soft Tissue Sarcoma

Who this might be right for
LiposarcomaLeiomyosarcomaFibrosarcoma+1 more
H. Lee Moffitt Cancer Center and Research Institute 48
Testing effectiveness (Phase 2)Study completedNCT00041808
What this trial is testing

Magnetic-Targeted Doxorubicin in Treating Patients With Cancer Metastatic to the Liver

Who this might be right for
Metastases, NeoplasmColorectal NeoplasmsEsophageal Neoplasms+9 more
FeRx 20
Not applicableLooking for participantsNCT06523582
What this trial is testing

Genetic Bases of Neuroendocrine Neoplasms in Mexican Patients

Who this might be right for
Neuroendocrine NeoplasmNeuroendocrine Neoplasm of Gastrointestinal TractNeuroendocrine Neoplasm of Lung+23 more
Universidad Nacional Autonoma de Mexico 750
Not applicableWithdrawnNCT01031056
What this trial is testing

Collection of Biospecimen & Clinical Information in Patients w/ Gastrointestinal Cancers

Who this might be right for
Gastrointestinal NeoplasmsGynecologic CancersGynecologic Cancers Cervical Cancer+11 more
Stanford University
Testing effectiveness (Phase 2)Active Not RecruitingNCT02834013
What this trial is testing

Nivolumab and Ipilimumab in Treating Patients With Rare Tumors

Who this might be right for
Acinar Cell CarcinomaAdenoid Cystic CarcinomaAdrenal Cortical Carcinoma+91 more
National Cancer Institute (NCI) 798
Testing effectiveness (Phase 2)Study completedNCT00568750
What this trial is testing

Dasatinib as First-Line Therapy in Treating Patients With Gastrointestinal Stromal Tumors

Who this might be right for
Gastrointestinal Stromal Tumor
Swiss Cancer Institute 47
Not applicableStudy completedNCT02877368
What this trial is testing

Sarcopenia in Patients With Gastrointestinal Stromal Tumours

Who this might be right for
Gastrointestinal Stromal Tumours
CHU de Reims 31
Not applicableLooking for participantsNCT07124000
What this trial is testing

DESTINY-PANTUMOUR04

Who this might be right for
Adenocarcinoma (NOS)Anal CancerBladder Cancer+24 more
AstraZeneca 100
Testing effectiveness (Phase 2)Looking for participantsNCT07559864
What this trial is testing

Comparing Regorafenib Combined With Envafolimab to Physician's Choice in Patients With Metastatic Gastrointestinal Stromal Tumors Harboring KIT Exon 17 Mutations Refractory to Standard Treatment

Who this might be right for
GIST - Gastrointestinal Stromal TumorKIT Gene Mutation
Jian Li 100
Next Page